Interventional device developer Boston Scientific of Natick, MA, has released financial results for its fiscal second quarter (end-June 30). For the period, the firm had net sales of $854 million, up 21% compared with $708 million reported for the second quarter of 2002. Net income for the quarter, excluding net special charges, was $126 million, an increase of 33% compared with $95 million, excluding net special charges, in the second quarter of 2002.
The net special charges for the quarter include purchased in-process research and development costs of $12 million (after tax) related to acquisitions, the company said.
By AuntMinnie.com staff writersJuly 23, 2003
Related Reading
Boston Scientific submits final module for Taxus trials, June 19, 2003
Boston Scientific inks deal for device-tracking technology, May 19, 2003
Boston Scientific names Patel as VP, May 15, 2003
Boston Scientific starts Taxus V clinical trials, March 18, 2003
FDA grants Boston Scientific stent expedited status, March 13, 2003
Copyright © 2003 AuntMinnie.com
